Sagility Limited Makes Investor & Analyst Day Video Recording Available Online

1 min read     Updated on 26 Mar 2026, 09:05 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Sagility Limited has made the video recording of its Investor & Analyst Day held on March 25, 2026, in Mumbai available on its website. The disclosure was made in compliance with SEBI regulations, with the recording accessible through the company's investor relations portal for stakeholders and market participants.

powered bylight_fuzz_icon
36041711

*this image is generated using AI for illustrative purposes only.

Sagility Limited has announced that the video recording of its Investor & Analyst Day is now available for viewing on the company's official website. The healthcare technology company made this disclosure to stock exchanges as part of its regulatory compliance obligations.

Event Details and Availability

The Investor & Analyst Day was conducted on March 25, 2026, in Mumbai. Following the event, Sagility has made the complete video recording accessible to investors, analysts, and other stakeholders through its investor relations portal.

Parameter: Details
Event Date: March 25, 2026
Location: Mumbai
Video Access: Company website investor relations section
Website Link: https://sagilityhealth.com/investor-relations/

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about material events and developments that could impact investor decisions.

The announcement was formally communicated to both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) by Company Secretary & Compliance Officer Satishkumar Sakharayapattana Seetharamaiah.

Company Information

Sagility Limited, formerly known as Sagility India Limited, operates in the healthcare technology sector. The company is headquartered in Bengaluru, Karnataka, with its registered office located at AMR Tech Park. The video recording provides investors with insights into the company's strategic direction and operational updates shared during the investor day presentation.

What strategic initiatives or growth targets did Sagility announce during the Investor Day that could impact its market position in 2026?

How might Sagility's strategic direction revealed in the presentation affect its competitive standing against other healthcare technology companies?

Will the insights shared during the Investor Day lead to changes in analyst recommendations or target prices for Sagility's stock?

like17
dislike

Nomura Initiates Buy Rating on Sagility with Rs 55 Target Price

1 min read     Updated on 25 Mar 2026, 09:01 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Nomura has initiated Buy coverage on Sagility with Rs 55 target price, projecting 20% EPS CAGR for FY26-28F driven by AI adoption and healthcare outsourcing tailwinds. The stock trades at 14x FY28F EPS, though risks include US payer decline, operational outsourcing slowdown, and new market competition.

powered bylight_fuzz_icon
35955104

*this image is generated using AI for illustrative purposes only.

Nomura has initiated coverage on Sagility with a Buy rating and set a target price of Rs 55, highlighting the company's potential to capitalize on emerging trends in the healthcare outsourcing sector.

Growth Projections and Valuation

The brokerage projects strong earnings growth for Sagility, expecting a 20% EPS CAGR for the period FY26-28F. This growth trajectory is supported by favorable industry dynamics and the company's positioning in the healthcare outsourcing space.

Metric Details
Target Price Rs 55
Rating Buy
EPS CAGR FY26-28F 20%
Current Valuation 14x FY28F EPS

Key Growth Drivers

Nomura identifies two primary tailwinds supporting Sagility's growth prospects:

  • AI Adoption: The integration of artificial intelligence technologies in healthcare operations is expected to drive demand for specialized outsourcing services
  • Healthcare Outsourcing Trends: Continued expansion of healthcare outsourcing activities presents significant opportunities for the company

Risk Factors

Despite the positive outlook, Nomura acknowledges several challenges that could impact Sagility's performance:

  • US Payer Decline: Potential reduction in US healthcare payer activities could affect revenue streams
  • Operational Outsourcing Slowdown: Any deceleration in operational outsourcing demand may impact growth momentum
  • New Market Entrants: Increased competition from new players entering the healthcare outsourcing space

The current valuation of 14x FY28F EPS suggests the stock is reasonably priced considering the projected growth trajectory and market opportunities in the healthcare outsourcing sector.

How will Sagility's AI integration timeline compare to competitors in the healthcare outsourcing space?

What specific measures is Sagility taking to mitigate potential revenue impact from declining US payer activities?

Which emerging markets or service segments could provide alternative growth avenues if operational outsourcing demand slows?

like20
dislike

More News on Sagility